Auditory evoked potentials in schizophrenic patients before and during neuroleptic treatment. Relationship to psychopathological state
- PMID: 8323986
- DOI: 10.1007/BF02190249
Auditory evoked potentials in schizophrenic patients before and during neuroleptic treatment. Relationship to psychopathological state
Abstract
The auditory evoked potential (AEP) components N1 and P2 were investigated under a no-task condition in a group of 14 acutely ill unmedicated schizophrenic patients and compared with the findings in an age- and sex-matched control group. In the patients, N1 latency was significantly increased, P2 latency and N1-P2 interpeak latency were reduced. There were significant relationships between AEP parameters and the psychopathological state evaluated by means of the brief psychiatric ratings scale (BPRS). The N1 and P2 latencies were negatively correlated with the BPRS subscore "anergia" and positively correlated with "agitation". In 8 of the patients, a standardized neuroleptic treatment was started with 10 mg haloperidol/day. After 2 weeks of treatment, BPRS scores and N1 amplitude had significantly decreased. However, there was no relationship between BPRS improvement and N1 amplitude reduction. N1 latency in the unmedicated state was negatively correlated with subsequent therapeutic response measured as proportional improvement of the BPRS score within 2 weeks. Thus, N1 latency may be seen as a psychophysiological measure with prognostic applications.
Similar articles
-
Schizophrenia, psychoticism, neuroleptics, and auditory evoked potentials.Pharmacopsychiatry. 1985 Sep;18(5):293-6. doi: 10.1055/s-2007-1017383. Pharmacopsychiatry. 1985. PMID: 4048264
-
Latency increase of auditory-evoked potential component N1 predicts poor neuroleptic response in schizophrenic patients.Pharmacopsychiatry. 1994 Mar;27(2):68-9. doi: 10.1055/s-2007-1014280. Pharmacopsychiatry. 1994. PMID: 7913236
-
Auditory evoked potentials as possible predictors of outcome in schizophrenic outpatients.Int J Psychophysiol. 1988 Aug;6(3):207-14. doi: 10.1016/0167-8760(88)90006-2. Int J Psychophysiol. 1988. PMID: 2900230
-
Dose-related effects of amisulpride on five dimensions of psychopathology in patients with acute exacerbation of schizophrenia.J Clin Psychopharmacol. 2002 Dec;22(6):554-60. doi: 10.1097/00004714-200212000-00004. J Clin Psychopharmacol. 2002. PMID: 12454554 Clinical Trial.
-
The N1 response and its applications.Audiol Neurootol. 1997 Sep-Oct;2(5):281-307. doi: 10.1159/000259253. Audiol Neurootol. 1997. PMID: 9390837 Review.
Cited by
-
Neurophysiology in psychosis: The quest for disease biomarkers.Transl Psychiatry. 2022 Mar 11;12(1):100. doi: 10.1038/s41398-022-01860-x. Transl Psychiatry. 2022. PMID: 35277479 Free PMC article. Review.
-
Glutamatergic and GABAergic Receptor Modulation Present Unique Electrophysiological Fingerprints in a Concentration-Dependent and Region-Specific Manner.eNeuro. 2023 Apr 20;10(4):ENEURO.0406-22.2023. doi: 10.1523/ENEURO.0406-22.2023. Print 2023 Apr. eNeuro. 2023. PMID: 36931729 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical